Habibzadeh F
Sci Rep. 2024; 14(1):15399.
PMID: 38965406
PMC: 11224252.
DOI: 10.1038/s41598-024-66289-2.
Sayed S, Dailah H, Nagarajan S, El Kareem A, Said A, Abdelwahab S
J Family Med Prim Care. 2024; 13(2):589-599.
PMID: 38605749
PMC: 11006055.
DOI: 10.4103/jfmpc.jfmpc_1137_23.
Habibzadeh F
Sci Rep. 2024; 14(1):5800.
PMID: 38461305
PMC: 10924941.
DOI: 10.1038/s41598-024-56515-2.
Hong H, Gouveia M, Ogwang M, Kerchan P, Reynolds S, Tenge C
Am J Hematol. 2023; 99(1):113-123.
PMID: 38009642
PMC: 10872868.
DOI: 10.1002/ajh.27149.
Archer N
Blood Adv. 2023; 7(19):5968-5969.
PMID: 37815815
PMC: 10580264.
DOI: 10.1182/bloodadvances.2023010547.
F-erythrocytes promote Plasmodium falciparum proliferation in sickle cell disease.
Archer N, Gnangnon B, Mikdar M, Ciuculescu M, Petersen N, Staffa S
Am J Hematol. 2023; 98(10):1598-1605.
PMID: 37584425
PMC: 11145631.
DOI: 10.1002/ajh.27042.
Association between hemoglobin variants and laboratory outcomes in patients infected with from South West Uganda.
Onohuean H, Onohuean F, Ayogu E
Future Sci OA. 2023; 9(7):FSO888.
PMID: 37485444
PMC: 10357393.
DOI: 10.2144/fsoa-2022-0067.
Association of sickle cell trait with adverse pregnancy outcomes in a population-based cohort.
Hulsizer J, Rifkin A, Shi Z, Wei J, Zheng S, Helfand B
Acta Obstet Gynecol Scand. 2023; 102(8):1100-1105.
PMID: 37358249
PMC: 10378004.
DOI: 10.1111/aogs.14622.
Balancing selection on genomic deletion polymorphisms in humans.
Aqil A, Speidel L, Pavlidis P, Gokcumen O
Elife. 2023; 12.
PMID: 36625544
PMC: 9943071.
DOI: 10.7554/eLife.79111.
The erythrocyte membrane properties of beta thalassaemia heterozygotes and their consequences for Plasmodium falciparum invasion.
Introini V, Marin-Menendez A, Nettesheim G, Lin Y, Kariuki S, Smith A
Sci Rep. 2022; 12(1):8934.
PMID: 35624125
PMC: 9142571.
DOI: 10.1038/s41598-022-12060-4.
Revisiting the malaria hypothesis: accounting for polygenicity and pleiotropy.
Ebel E, Uricchio L, Petrov D, Egan E
Trends Parasitol. 2022; 38(4):290-301.
PMID: 35065882
PMC: 8916997.
DOI: 10.1016/j.pt.2021.12.007.
Artemisinin derivative-containing therapies and abnormal hemoglobin: Do we need to adapt the treatment?.
Gbessi E, Toure O, Gnondjui A, Koui T, Coulibaly B, Ako B
Parasite. 2021; 28:67.
PMID: 34569928
PMC: 8475499.
DOI: 10.1051/parasite/2021063.
A balancing act between primate lentiviruses and their receptor.
Ohainle M, Malik H
Proc Natl Acad Sci U S A. 2021; 118(20).
PMID: 33879567
PMC: 8157948.
DOI: 10.1073/pnas.2104741118.
Surveillance for sickle cell disease, United Republic of Tanzania.
Ambrose E, Smart L, Charles M, Hernandez A, Latham T, Hokororo A
Bull World Health Organ. 2020; 98(12):859-868.
PMID: 33293746
PMC: 7716099.
DOI: 10.2471/BLT.20.253583.
Prevalence of sickle cell disorders and malaria infection in children aged 1-12 years in the Volta Region, Ghana: a community-based study.
Oppong M, Lamptey H, Kyei-Baafour E, Aculley B, Ofori E, Tornyigah B
Malar J. 2020; 19(1):426.
PMID: 33228681
PMC: 7684914.
DOI: 10.1186/s12936-020-03500-5.
Genomic trade-offs: are autism and schizophrenia the steep price of the human brain?.
Sikela J, Searles Quick V
Hum Genet. 2018; 137(1):1-13.
PMID: 29335774
PMC: 5898792.
DOI: 10.1007/s00439-017-1865-9.
Significantly elevated foetal haemoglobin levels in individuals with glucose 6-phosphate dehydrogenase disease and/or sickle cell trait: a cross-sectional study in Cape Coast, Ghana.
Adu P, Bashirudeen E, Haruna F, Adela E, Ephraim R
BMC Hematol. 2017; 17:16.
PMID: 29021902
PMC: 5613503.
DOI: 10.1186/s12878-017-0088-6.
High birth prevalence of sickle cell disease in Northwestern Tanzania.
Ambrose E, Makani J, Chami N, Masoza T, Kabyemera R, Peck R
Pediatr Blood Cancer. 2017; 65(1).
PMID: 28766840
PMC: 5701733.
DOI: 10.1002/pbc.26735.
Age and geographic patterns of Plasmodium falciparum malaria infection in a representative sample of children living in Burkitt lymphoma-endemic areas of northern Uganda.
Maziarz M, Kinyera T, Otim I, Kagwa P, Nabalende H, Legason I
Malar J. 2017; 16(1):124.
PMID: 28320389
PMC: 5360076.
DOI: 10.1186/s12936-017-1778-z.
Hydroxycarbamine: from an Old Drug Used in Malignant Hemopathies to a Current Standard in Sickle Cell Disease.
Cannas G, Poutrel S, Thomas X
Mediterr J Hematol Infect Dis. 2017; 9(1):e2017015.
PMID: 28293403
PMC: 5333733.
DOI: 10.4084/MJHID.2017.015.
